Boothbay Fund Management, LLC Harmony Biosciences Holdings, Inc. Transaction History
Boothbay Fund Management, LLC
- $3.6 Billion
- Q3 2024
A detailed history of Boothbay Fund Management, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 7,947 shares of HRMY stock, worth $300,714. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,947Holding current value
$300,714% of portfolio
0.01%Shares
4 transactions
Others Institutions Holding HRMY
# of Institutions
250Shares Held
48.8MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$424 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$221 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$179 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$86.3 Million0.19% of portfolio
-
State Street Corp Boston, MA1.24MShares$46.9 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.24B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...